-0.05 | -0.13%
| Price and Volume | |
|---|---|
| Recent Price | 37.55 |
| 52 Week High | 39.50 |
| 52 Week Low | 29.47 |
| Avg. Daily Vol. (Mil) | 14.03 |
| Beta (3 year) | 0.44 |
| Share Related Items | |
| Mkt Cap (Mil) | 114,210.75 |
| Shares Out (Mil) | 3,041.56 |
| Float (Mil) | 3,041.61 |
| Dividend Information | |
| Yield % | 4.50 |
| Annual Dividend | 1.68 |
| Payout Ratio | 71.00 |
| Financial Strength | |
| Quick Ratio | 1.50 |
| Current Ratio | 2.10 |
| LT Debt/ Equity | 0.28 |
| Total Debt / Equity | 0.33 |
| Valuation Ratios | |
| Price Earnings | 16.70 |
| Price/Sales | 2.37 |
| Price/Book | 2.08 |
| Price/Cash Flow | 8.00 |
| Per Share Data | |
| Earnings | 2.25 |
| Sales | 15.85 |
| Book Value | 18.04 |
| Cash Flow | 4.71 |
| Business Summary | |
|---|---|
| Merck & Co., Inc. is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. | |
| General Information | |
| One Merck Drive
Whitehouse Station, NJ 08889-0100 |
|
| www.merck.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 86000 | |
| CEO: Kenneth C. Frazier | |
| Short Interest | |
| Current Month (Mil) | 17.18 |
| Previous Month (Mil) | 18.99 |
| Short Interest Ratio (Days) | 1.40 |
| Management Effectiveness | |
| Return on Equity | 12.70 |
| Return on Assets | 6.60 |
| Return on Investments | 9.90 |
| Profitability | |
| Gross Margin | 80.40 |
| EBIT Margin | 18.40 |
| Profit Margin | 14.50 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet